3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
4
Pancreatic Neoplasms
2
Uterine Cervical Neoplasms
1
Thyroid Cancer, Papillary
1
Myasthenia Gravis
1
Kidney Neoplasms
1
Fanconi Anemia, Complementation Group D1
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Diseases
1
Breast Carcinoma In Situ
1
Interventions
abemaciclib
2
Blood Specimen Collection
2
ribociclib
1
palbociclib
1
Watchful Waiting
1
Surgical Procedures, Operative
1
Letrozole
1
Lead
1
High-Energy Shock Waves
1
Genotype
1
Fulvestrant
1
Bone Density
1
Body Height
1
Blood Pressure
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Breast Diseases
×
Genotype
×
Clear all
NCT05006196
2026-05-20
IMOGEN
Perspectum
Active not recruiting
1,030 enrolled